AFYA

Afya Limited

Price Chart

No historical data available

Latest Quote

$14.63

+0.32 (+2.24%)
Current Price
Previous Close $14.31
Open $14.38
Day High $14.70
Day Low $14.27
Volume 66,662
Fetched: 2026-08-28T18:17:40
Stock Information
Note: Financial values converted from BRL to USD
Quarterly Dividend / Yield $0.66 / 4.58%
Shares Outstanding 49.90M
Quarterly Dividend Yield 4.58%
Quarterly Dividend $0.66
Total Debt $598.28M
Cash Equivalents $193.11M
Revenue $734.15M
Net Income $150.09M
Sector Consumer Defensive
Industry Education & Training Services
Market Cap $1.29B
P/E Ratio 8.71
EPS (TTM) $1.68
Exchange NMS
🌐 Visit Website
Recent Price History
No history data available. Data will be fetched automatically.
About Afya Limited

Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergraduate, Continuing Education, and Medical Practice Solutions. The Undergraduate segment offers educational services through undergraduate courses related to medical school, health sciences, and other non-health undergraduate programs, including medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, biomedicine, business administration, accounting, law, civil and industrial engineering, and pedagogy. The Continuing Education segment provides medical education, including residency preparation programs, specialization test preparation, graduate courses in medicine, and digital and in-person professional development for physicians and medical students. The Medical Practice Solutions segment offers clinical decision support platforms, medical practice management software, healthcare financial services, and digital healthcare ecosystem solutions, such as electronic medical records, practice management tools, telemedicine, digital prescriptions, and doctor-patient relationship platforms. This segment also provides a subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. The company also offers educational health and medical imaging; and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. In addition, it offers printed and digital content, as well as an online medical education platform and physicians, healthcare professionals and students. Afya Limited was founded in 1999 and is headquartered in Belo Horizonte, Brazil.

📰 Latest News
No news articles available at the moment. Check back later for updates on AFYA.
Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Reconciled Cost Of Revenue $255,790,787 $236,655,172 $216,059,838 $167,338,701
Cost Of Revenue $255,790,787 $236,655,172 $216,059,838 $167,338,701
Total Revenue $719,786,410 $643,291,065 $559,886,482 $453,423,845
Operating Revenue $911,949,897 $788,922,412 $682,406,627 $550,474,419
Expenses
Interest Expense $85,551,919 $71,321,884 $75,204,607 $56,195,147
Total Expenses $483,616,578 $446,251,591 $410,554,049 $324,170,646
Other Income Expense $2,106,646 $543,745 $1,715,921 $15,573,336
Net Non Operating Interest Income Expense $-70,666,586 $-65,902,540 $-67,416,771 $-61,418,641
Total Other Finance Cost $21,711,443 $14,593,505 $13,066,814 $10,518,241
Interest Expense Non Operating $85,551,919 $71,321,884 $75,204,607 $56,195,147
Operating Expense $227,825,791 $209,596,418 $194,494,211 $156,831,946
Other Operating Expenses $18,495 $1,419,616 $-3,045,789 $1,411,829
Rent Expense Supplemental - - $2,116,380 $2,365,962
General And Administrative Expense - - $197,540,000 $155,385,464
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $146,490,086 $122,943,188 $75,210,059 $72,726,899
Net Interest Income $-70,666,586 $-65,902,540 $-67,416,771 $-61,418,641
Interest Income $36,596,775 $20,012,848 $20,854,650 $5,294,747
Normalized Income $147,027,886 $124,613,699 $75,335,186 $60,625,231
Net Income From Continuing And Discontinued Operation $146,490,086 $122,943,188 $75,210,059 $72,726,899
Total Operating Income As Reported $236,169,832 $197,039,475 $149,332,433 $129,287,851
Net Income Common Stockholders $146,490,086 $122,943,188 $75,210,059 $72,726,899
Net Income $146,490,086 $122,943,188 $75,210,059 $72,726,899
Net Income Including Noncontrolling Interests $149,601,482 $126,332,589 $78,926,914 $76,462,249
Net Income Continuous Operations $149,601,482 $126,332,589 $78,926,914 $76,462,249
Pretax Income $167,609,892 $131,680,679 $83,631,582 $83,407,893
Earnings From Equity Interest $2,709,185 $2,284,974 $1,848,499 $2,371,997
Interest Income Non Operating $36,596,775 $20,012,848 $20,854,650 $5,294,747
Operating Income $236,169,832 $197,039,475 $149,332,433 $129,253,198
Gross Profit $463,995,623 $406,635,893 $343,826,644 $286,085,144
Per Share
Diluted EPS $1.60 $1.35 $0.83 $0.80
Basic EPS $1.62 $1.36 $0.84 $0.81
Other
Tax Effect Of Unusual Items $-64,738 $-70,718 $-7,451 $1,099,672
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $326,447,444 $269,639,052 $215,331,145 $166,548,879
Total Unusual Items $-602,539 $-1,741,230 $-132,578 $13,201,339
Total Unusual Items Excluding Goodwill $-602,539 $-1,741,230 $-132,578 $13,201,339
Reconciled Depreciation $72,683,095 $64,895,259 $56,362,378 $40,147,178
EBITDA (Bullshit earnings) $325,844,906 $267,897,822 $215,198,568 $179,750,218
EBIT $253,161,810 $203,002,563 $158,836,190 $139,603,040
Diluted Average Shares $17,768,097 $17,746,103 $17,625,830 $17,508,964
Basic Average Shares $17,613,962 $17,545,152 $17,488,290 $17,508,964
Diluted NI Availto Com Stockholders $146,490,086 $122,943,188 $75,210,059 $72,726,899
Minority Interests $-3,111,397 $-3,389,401 $-3,716,855 $-3,735,350
Tax Provision $18,008,410 $5,348,090 $4,704,668 $6,945,645
Gain On Sale Of Security $-602,539 $-1,741,230 $-132,578 $13,201,339
Provision For Doubtful Accounts $11,114,355 $11,854,923 $14,513,880 -
Selling General And Administration $216,692,941 $196,321,879 $183,026,120 $155,385,464
Excise Taxes $37,861,035 $33,218,081 $27,805,357 $20,831,678
Other Taxes - $189,814 $379,044 $34,653
Other Gand A - - $197,540,000 $155,385,464
Fetched: 2026-08-24
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $-143,321,258 $-245,850,165 $-232,548,954 $-164,048,781
Total Assets $1,821,814,756 $1,718,946,131 $1,476,556,621 $1,401,615,612
Total Non Current Assets $1,443,709,408 $1,409,444,915 $1,242,256,508 $1,082,794,418
Other Non Current Assets $24,428,610 $22,558,696 $22,845,072 $37,331,307
Non Current Deferred Assets $2,443,640 $0 - -
Non Current Deferred Taxes Assets $2,443,640 $0 - -
Non Current Accounts Receivable $6,810,925 $6,998,403 $7,686,991 $8,287,194
Goodwill And Other Intangible Assets $1,087,875,211 $1,077,130,555 $933,694,630 $786,802,722
Other Intangible Assets $790,648,846 $779,904,190 $673,853,693 $542,079,567
Current Assets $378,105,349 $309,501,216 $234,300,113 $318,821,194
Other Current Assets $12,254,604 $11,125,063 $11,736,752 $10,073,784
Receivables $146,760,109 $121,018,568 $114,898,762 $93,571,620
Taxes Receivable $7,101,000 $5,008,371 $8,517,502 $5,413,892
Accounts Receivable $139,659,108 $116,010,197 $106,381,260 $88,157,728
Cash Cash Equivalents And Short Term Investments $219,090,636 $177,357,585 $107,664,599 $212,802,625
Cash And Cash Equivalents $219,090,636 $177,357,585 $107,664,599 $212,802,625
Cash Equivalents $216,078,916 $176,174,312 $105,377,873 $201,606,698
Cash Financial $3,011,720 $1,183,273 $2,286,727 $11,195,927
Inventory - - $269,050 $2,373,165
Allowance For Doubtful Accounts Receivable - - $-11,953,042 $-8,574,933
Gross Accounts Receivable - - $118,334,303 $96,732,660
Debt
Net Debt $180,836,734 $249,999,213 $242,912,619 $165,867,494
Total Debt $607,408,187 $617,820,522 $520,839,448 $528,482,246
Long Term Debt And Capital Lease Obligation $584,739,496 $538,169,783 $478,759,085 $481,790,467
Long Term Debt $388,116,445 $356,579,632 $315,680,206 $338,297,500
Current Debt And Capital Lease Obligation $22,668,691 $79,650,739 $42,080,363 $46,691,779
Current Debt $11,810,925 $70,777,165 $34,897,012 $40,372,619
Other Current Borrowings $11,810,925 $70,777,165 $34,897,012 $40,372,619
Liabilities
Total Liabilities Net Minority Interest $869,592,502 $879,756,229 $767,330,309 $768,870,627
Total Non Current Liabilities Net Minority Interest $697,486,251 $657,781,584 $561,247,109 $592,549,915
Other Non Current Liabilities $8,462,991 $8,321,068 $3,558,774 $2,573,297
Tradeand Other Payables Non Current $79,321,728 $83,685,898 $58,612,115 $70,057,039
Non Current Deferred Liabilities $0 $5,504,419 - -
Current Liabilities $172,106,251 $221,974,645 $206,083,200 $176,320,712
Other Current Liabilities $1,741,619 $2,109,567 $539,851 $529,338
Current Deferred Liabilities $30,766,459 $31,353,034 $29,880,659 $25,902,347
Payables And Accrued Expenses $74,581,238 $68,352,799 $96,146,280 $73,115,482
Payables $74,581,238 $68,352,799 $96,146,280 $73,115,482
Dividends Payable $37,379 $0 - -
Total Tax Payable $28,945,410 $7,340,069 $6,160,690 $8,249,036
Income Tax Payable $21,928,512 $826,811 $755,363 $3,144,298
Accounts Payable $45,598,449 $61,012,730 $89,985,590 $64,866,446
Current Notes Payable - - $0 -
Equity
Common Stock Equity $944,553,953 $831,280,390 $701,145,675 $622,753,940
Total Equity Gross Minority Interest $952,222,254 $839,189,902 $709,226,312 $632,744,985
Stockholders Equity $944,553,953 $831,280,390 $701,145,675 $622,753,940
Other Equity Interest $39,484,288 $36,502,160 $30,189,813 $24,050,538
Retained Earnings $512,898,008 $391,674,440 $268,731,253 $195,632,513
Long Term Equity Investment $9,056,185 $10,598,839 $10,091,111 $10,494,685
Other
Treasury Shares Number $750,526 $672,729 $734,626 $737,119
Ordinary Shares Number $17,495,557 $17,573,354 $17,511,457 $17,508,964
Share Issued $18,246,083 $18,246,083 $18,246,083 $18,246,083
Tangible Book Value $-143,321,258 $-245,850,165 $-232,548,954 $-164,048,781
Invested Capital $1,344,481,323 $1,258,637,188 $1,051,722,893 $1,001,424,059
Working Capital $205,999,097 $87,526,571 $28,216,913 $142,500,482
Capital Lease Obligations $207,480,817 $190,463,724 $170,262,230 $149,812,127
Total Capitalization $1,332,670,398 $1,187,860,022 $1,016,825,881 $961,051,441
Minority Interest $7,668,302 $7,909,512 $8,080,637 $9,991,044
Treasury Stock $59,574,425 $53,333,916 $58,238,911 $59,367,478
Additional Paid In Capital $451,742,772 $456,434,396 $460,460,211 $462,435,058
Capital Stock $3,310 $3,310 $3,310 $3,310
Common Stock $3,310 $3,310 $3,310 $3,310
Long Term Capital Lease Obligation $196,623,051 $181,590,151 $163,078,879 $143,492,967
Long Term Provisions $24,962,036 $22,100,416 $20,317,135 $38,129,111
Current Deferred Revenue $30,766,459 $31,353,034 $29,880,659 $25,902,347
Current Capital Lease Obligation $10,857,765 $8,873,574 $7,183,351 $6,319,160
Pensionand Other Post Retirement Benefit Plans Current $42,348,244 $40,508,506 $37,436,046 $30,081,765
Investments And Advances $9,056,185 $10,598,839 $10,091,111 $10,494,685
Investmentsin Associatesat Cost $9,056,185 $10,598,839 $10,091,111 $10,494,685
Goodwill $297,226,365 $297,226,365 $259,840,936 $244,723,155
Net PPE $313,094,838 $292,158,422 $267,938,705 $239,878,511
Accumulated Depreciation $-64,862,358 $-45,014,210 $-28,949,304 $-19,325,234
Gross PPE $377,957,196 $337,172,632 $296,888,009 $259,203,745
Leases $68,423,079 $60,236,925 $51,483,080 $28,393,489
Construction In Progress $13,469,220 $8,572,596 $6,611,766 $16,876,533
Other Properties $181,327,915 $170,496,431 $155,647,115 $141,617,991
Machinery Furniture Equipment $89,943,539 $74,851,845 $61,325,388 $50,762,760
Buildings And Improvements $21,123,310 $19,344,702 $18,150,527 $17,882,840
Land And Improvements $3,670,132 $3,670,132 $3,670,132 $3,670,132
Properties $0 $0 $0 $0
Fetched: 2026-08-24
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $227,305,214 $202,477,118 $155,393,640 $106,466,336
Operating Activities
Operating Cash Flow $298,171,348 $278,911,917 $203,173,882 $164,291,354
Cash Flow From Continuing Operating Activities $298,171,348 $278,911,917 $203,173,882 $164,291,354
Operating Gains Losses $-2,355,644 $-916,949 $-1,715,921 $-2,206,128
Investing Activities
Capital Expenditure $-70,866,135 $-76,434,799 $-47,780,242 $-57,825,018
Investing Cash Flow $-98,717,047 $-212,516,638 $-222,530,655 $-115,147,954
Cash Flow From Continuing Investing Activities $-98,717,047 $-212,516,638 $-222,530,655 $-115,147,954
Net Other Investing Changes - - - -
Financing Activities
Financing Cash Flow $-157,367,709 $4,665,732 $-85,648,675 $18,094,069
Cash Flow From Continuing Financing Activities $-157,367,709 $4,665,732 $-85,648,675 $18,094,069
Net Other Financing Charges $-28,581,746 $-3,560,526 $-3,650,274 $-3,842,230
Cash Dividends Paid $0 $0 $0 $0
Net Common Stock Issuance $-14,990,849 $0 $-2,408,013 $-29,653,272
Dividends Received Cfi $3,027,878 $1,460,304 $1,927,345 $1,314,878
Repurchase Of Capital Stock - - $-2,408,013 $-29,653,272
Issuance Of Capital Stock - - - $0
Common Stock Issuance - - - $0
Other
Repayment Of Debt $-325,959,184 $-33,079,662 $-28,054,159 $-5,899,233
Issuance Of Debt $291,025,376 $95,703,964 $1,029,475 $96,734,218
End Cash Position $219,090,636 $177,357,585 $107,664,599 $212,802,625
Beginning Cash Position $177,357,585 $107,664,599 $212,802,625 $145,731,023
Effect Of Exchange Rate Changes $-353,541 $-1,368,025 $-132,578 $-165,868
Changes In Cash $42,086,593 $71,061,011 $-105,005,447 $67,237,470
Interest Paid Cff $-83,871,040 $-56,223,375 $-54,471,828 $-39,245,414
Proceeds From Stock Option Exercised $5,009,734 $1,825,332 $1,906,125 $0
Net Issuance Payments Of Debt $-34,933,807 $62,624,302 $-27,024,685 $90,834,985
Net Long Term Debt Issuance $-34,933,807 $62,624,302 $-27,024,685 $90,834,985
Long Term Debt Payments $-325,959,184 $-33,079,662 $-28,054,159 $-5,899,233
Long Term Debt Issuance $291,025,376 $95,703,964 $1,029,475 $96,734,218
Interest Received Cfi $-2,829,887 $-15,366,390 $-13,923,217 $-4,584,745
Net Business Purchase And Sale $-28,048,903 $-122,175,754 $-162,754,540 $-54,053,068
Purchase Of Business $-28,048,903 $-122,175,754 $-162,754,540 $-54,053,068
Net Intangibles Purchase And Sale $-38,546,313 $-49,778,256 $-24,723,162 $-25,092,862
Purchase Of Intangibles $-38,546,313 $-49,778,256 $-24,723,162 $-25,092,862
Net PPE Purchase And Sale $-32,319,821 $-26,656,542 $-23,057,080 $-32,732,156
Purchase Of PPE $-32,319,821 $-26,656,542 $-23,057,080 $-32,732,156
Taxes Refund Paid $-3,123,856 $-3,994,860 $-8,788,693 $-6,441,810
Change In Working Capital $-41,466,533 $-4,672,546 $-14,829,653 $-21,399,953
Change In Other Working Capital $-84,881 $1,967,449 $-612,857 $5,769,186
Change In Other Current Liabilities $1,790,289 $5,974,185 $-8,282,132 $-2,494,062
Change In Other Current Assets $-2,102,169 $2,184,324 $17,215,083 $-274,695
Change In Payables And Accrued Expense $-4,401,355 $647,899 $5,407,857 $1,179,769
Change In Payable $-4,401,355 $647,899 $5,407,857 $1,179,769
Change In Account Payable $-875,871 $3,528,793 $4,769,692 $1,941,946
Change In Tax Payable $-3,525,484 $-2,880,894 $638,165 $-762,177
Change In Income Tax Payable $-3,525,484 $-2,880,894 $638,165 $-762,177
Change In Receivables $-36,668,418 $-15,446,404 $-28,557,605 $-25,580,149
Changes In Account Receivables $-34,575,788 $-18,971,498 $-25,568,663 $-25,146,010
Other Non Cash Items $90,078,259 $73,211,266 $67,408,789 $56,046,021
Stock Based Compensation $2,982,128 $6,312,346 $6,139,275 $6,088,463
Provisionand Write Offof Assets $11,114,355 $11,854,923 $14,513,880 $8,314,449
Asset Impairment Charge $649,651 $541,798 $452,245 $335,241
Depreciation Amortization Depletion $72,683,095 $64,895,259 $56,362,378 $40,147,178
Depreciation And Amortization $72,683,095 $64,895,259 $56,362,378 $40,147,178
Earnings Losses From Equity Investments $-2,709,185 $-2,284,974 $-1,848,499 $-2,371,997
Net Foreign Currency Exchange Gain Loss $353,541 $1,368,025 $132,578 $165,868
Net Income From Continuing Operations $167,609,892 $131,680,679 $83,631,582 $83,407,893
Common Stock Payments - - $-2,408,013 $-29,653,272
Change In Inventory - - $2,131,176 $-70,669
Gain Loss On Sale Of PPE - - - -
Fetched: 2026-08-24